Back to Search Start Over

Clinical and technical challenges of cancer reirradiation: Words of wisdom

Authors :
Arnaud Beddok
Valentin Calugaru
Ludovic de Marzi
Pierre Graff
Jean-Luc Dumas
Farid Goudjil
Rémi Dendale
Mathieu Minsat
Pierre Verrelle
Irène Buvat
Gilles Créhange
Laboratoire d'Imagerie Translationnelle en Oncologie (LITO )
Institut Curie [Paris]-Institut National de la Santé et de la Recherche Médicale (INSERM)
Institut Curie Centre de Protonthérapie d'Orsay
Institut Curie [Paris]
Buvat, Irène
Source :
Critical Reviews in Oncology/Hematology, Critical Reviews in Oncology/Hematology, 2022, 174, pp.103655. ⟨10.1016/j.critrevonc.2022.103655⟩
Publication Year :
2021

Abstract

International audience; Since the development of new radiotherapy techniques that have improved healthy tissue sparing, reirradiation (reRT) has become possible. The selection of patients eligible for reRT is complex given that it can induce severe or even fatal side effects. The first step should therefore be to assess, in the context of multidisciplinary staff meeting, the patient's physical status, the presence of sequelae resulting from the first irradiation and the best treatment option available. ReRT can be performed either curatively or palliatively to treat a cancer-related symptom that is detrimental to the patient's quality of life. The selected techniques for reRT should provide the best protection of healthy tissue. The construction of target volumes and the evaluation of constraints regarding the doses that can be used in this context have not yet been fully codified. These points raised in the literature suggest that randomized studies should be undertaken to answer pending questions.

Details

ISSN :
18790461 and 10408428
Volume :
174
Database :
OpenAIRE
Journal :
Critical reviews in oncology/hematology
Accession number :
edsair.doi.dedup.....b8e3bab7225385d6fa819c0f68551f92
Full Text :
https://doi.org/10.1016/j.critrevonc.2022.103655⟩